State of Wyoming’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174K Sell
2,803
-7
-0.2% -$441 0.02% 1037
2025
Q4
$157K Buy
2,810
+476
+20% +$27.6K 0.02% 1114
2025
Q3
$147K Buy
2,334
+23
+1% +$1.36K 0.02% 1116
2025
Q2
$132K Buy
+2,311
New +$126K 0.02% 1163
2024
Q4
Sell
-2,308
Closed -$154K 1873
2024
Q3
$154K Buy
2,308
+466
+25% +$31.6K 0.02% 881
2024
Q2
$123K Buy
+1,842
New +$125K 0.02% 887
2022
Q2
Sell
-211
Closed -$19K 2148
2022
Q1
$19K Buy
211
+29
+16% +$2.67K 0.01% 1456
2021
Q4
$18K Buy
182
+1
+0.6% +$102 0.01% 1510
2021
Q3
$17K Buy
181
+34
+23% +$3K 0.01% 968
2021
Q2
$13K Buy
+147
New +$12.7K 0.01% 989

Other funds holding UTMD

State of Wyoming's UTMD Position: Q1 2026 in Review

State of Wyoming reduced its Utah Medical Products (UTMD) stake by 0.25% in Q1 2026, selling an estimated $441 and leaving 2,803 shares worth $174K. The position accounts for 0.02% of the portfolio, ranked #1037.

State of Wyoming first reported a position in UTMD in Q2 2021 and has held it in 10 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • State of Wyoming held 2,803 shares of Utah Medical Products worth $174K as of Q1 2026.
  • State of Wyoming sold 7 Utah Medical Products shares in Q1 2026, an estimated $441.
  • Utah Medical Products made up 0.02% of State of Wyoming's portfolio in Q1 2026, its #1037 holding.
  • State of Wyoming first reported a position in Utah Medical Products in Q2 2021 and has held it in 10 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.